News
Regulatory affairsRegulatory Round-up - April 2026
Cell and Gene Therapy Catapult, UCLB and Imperial Innovations announce positive interim review in ongoing AML WT1 T cell clinical trialCell and Gene Therapy Catapult and Asymptote sign licence agreement for thawing system for cell-based therapiesFrameworks for promising therapies with less mature evidence base to secure adoptionCell and Gene Therapy Catapult appoints three new Non-Executive Directors to the BoardCell Therapy Catapult is now the Cell and Gene Therapy CatapultReNeuron wins major UK grant to advance its exosome nanomedicine platformSynpromics and Cell Therapy Catapult collaborate to develop novel large scale viral vector manufacturing platform based on stable producer cell linesCell Therapy Catapult, University of Birmingham and Cancer Research Technology launch new collaboration for CAR-T cell immuno-oncology therapy developmentHorizon 2020 awards €6.8m to TETRA consortium for pivotal replacement trachea trialCell Therapy Catapult details key milestones and achievements in 2015 Annual ReviewCell Therapy Catapult signs Memorandum of Understanding with Kanagawa Prefecture, JapanBIA publishes briefing paper on ATMPs and regenerative medicine